nodes	percent_of_prediction	percent_of_DWPC	metapath
Timolol—ABCB1—Mitomycin—urinary bladder cancer	0.23	0.474	CbGbCtD
Timolol—ABCB1—Gemcitabine—urinary bladder cancer	0.0661	0.136	CbGbCtD
Timolol—ABCB1—Cisplatin—urinary bladder cancer	0.048	0.0991	CbGbCtD
Timolol—ABCB1—Etoposide—urinary bladder cancer	0.0472	0.0974	CbGbCtD
Timolol—ABCB1—Doxorubicin—urinary bladder cancer	0.0322	0.0664	CbGbCtD
Timolol—ABCB1—Methotrexate—urinary bladder cancer	0.0312	0.0643	CbGbCtD
Timolol—CYP2D6—Doxorubicin—urinary bladder cancer	0.0303	0.0626	CbGbCtD
Timolol—ADRB3—prostate gland—urinary bladder cancer	0.00616	0.211	CbGeAlD
Timolol—CYP2C19—urine—urinary bladder cancer	0.00561	0.192	CbGeAlD
Timolol—ADRB3—female reproductive system—urinary bladder cancer	0.00336	0.115	CbGeAlD
Timolol—CYP2D6—urine—urinary bladder cancer	0.00327	0.112	CbGeAlD
Timolol—ADRB1—prostate gland—urinary bladder cancer	0.00252	0.0863	CbGeAlD
Timolol—ADRB1—female reproductive system—urinary bladder cancer	0.00137	0.0471	CbGeAlD
Timolol—CYP2C19—vagina—urinary bladder cancer	0.000995	0.0341	CbGeAlD
Timolol—ABCB1—prostate gland—urinary bladder cancer	0.000843	0.0289	CbGeAlD
Timolol—CYP2D6—renal system—urinary bladder cancer	0.000799	0.0274	CbGeAlD
Timolol—ABCB1—seminal vesicle—urinary bladder cancer	0.000713	0.0244	CbGeAlD
Timolol—CYP2D6—female reproductive system—urinary bladder cancer	0.00064	0.0219	CbGeAlD
Timolol—ABCB1—epithelium—urinary bladder cancer	0.00062	0.0212	CbGeAlD
Timolol—ABCB1—renal system—urinary bladder cancer	0.000575	0.0197	CbGeAlD
Timolol—ABCB1—urethra—urinary bladder cancer	0.000565	0.0193	CbGeAlD
Timolol—ABCB1—female reproductive system—urinary bladder cancer	0.00046	0.0158	CbGeAlD
Timolol—ABCB1—vagina—urinary bladder cancer	0.000416	0.0143	CbGeAlD
Timolol—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000403	0.00084	CcSEcCtD
Timolol—Headache—Thiotepa—urinary bladder cancer	0.000401	0.000836	CcSEcCtD
Timolol—Decreased appetite—Etoposide—urinary bladder cancer	0.0004	0.000833	CcSEcCtD
Timolol—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000397	0.000827	CcSEcCtD
Timolol—Body temperature increased—Cisplatin—urinary bladder cancer	0.000397	0.000827	CcSEcCtD
Timolol—Fatigue—Etoposide—urinary bladder cancer	0.000396	0.000826	CcSEcCtD
Timolol—Pain—Etoposide—urinary bladder cancer	0.000393	0.000819	CcSEcCtD
Timolol—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000393	0.000819	CcSEcCtD
Timolol—Dysuria—Doxorubicin—urinary bladder cancer	0.000392	0.000817	CcSEcCtD
Timolol—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00039	0.000813	CcSEcCtD
Timolol—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.00039	0.000812	CcSEcCtD
Timolol—Sweating—Epirubicin—urinary bladder cancer	0.000387	0.000807	CcSEcCtD
Timolol—Asthenia—Gemcitabine—urinary bladder cancer	0.000386	0.000805	CcSEcCtD
Timolol—Epistaxis—Epirubicin—urinary bladder cancer	0.000381	0.000794	CcSEcCtD
Timolol—Pruritus—Gemcitabine—urinary bladder cancer	0.000381	0.000794	CcSEcCtD
Timolol—Nausea—Thiotepa—urinary bladder cancer	0.00038	0.000792	CcSEcCtD
Timolol—Weight decreased—Doxorubicin—urinary bladder cancer	0.000379	0.000791	CcSEcCtD
Timolol—Sinusitis—Epirubicin—urinary bladder cancer	0.000379	0.00079	CcSEcCtD
Timolol—Feeling abnormal—Etoposide—urinary bladder cancer	0.000379	0.00079	CcSEcCtD
Timolol—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000378	0.000788	CcSEcCtD
Timolol—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000377	0.000786	CcSEcCtD
Timolol—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000376	0.000784	CcSEcCtD
Timolol—Pruritus—Fluorouracil—urinary bladder cancer	0.000374	0.000781	CcSEcCtD
Timolol—Visual impairment—Methotrexate—urinary bladder cancer	0.000373	0.000779	CcSEcCtD
Timolol—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00037	0.000771	CcSEcCtD
Timolol—Bradycardia—Epirubicin—urinary bladder cancer	0.000369	0.00077	CcSEcCtD
Timolol—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000368	0.000768	CcSEcCtD
Timolol—Urticaria—Etoposide—urinary bladder cancer	0.000365	0.000761	CcSEcCtD
Timolol—Rhinitis—Epirubicin—urinary bladder cancer	0.000364	0.000758	CcSEcCtD
Timolol—Abdominal pain—Etoposide—urinary bladder cancer	0.000363	0.000757	CcSEcCtD
Timolol—Body temperature increased—Etoposide—urinary bladder cancer	0.000363	0.000757	CcSEcCtD
Timolol—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000363	0.000757	CcSEcCtD
Timolol—Eye disorder—Methotrexate—urinary bladder cancer	0.000362	0.000755	CcSEcCtD
Timolol—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000362	0.000755	CcSEcCtD
Timolol—Tinnitus—Methotrexate—urinary bladder cancer	0.000361	0.000753	CcSEcCtD
Timolol—Asthenia—Cisplatin—urinary bladder cancer	0.00036	0.00075	CcSEcCtD
Timolol—Cardiac disorder—Methotrexate—urinary bladder cancer	0.00036	0.00075	CcSEcCtD
Timolol—Sweating—Doxorubicin—urinary bladder cancer	0.000358	0.000747	CcSEcCtD
Timolol—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000357	0.000745	CcSEcCtD
Timolol—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000356	0.000743	CcSEcCtD
Timolol—Epistaxis—Doxorubicin—urinary bladder cancer	0.000353	0.000735	CcSEcCtD
Timolol—Angiopathy—Methotrexate—urinary bladder cancer	0.000352	0.000733	CcSEcCtD
Timolol—Sinusitis—Doxorubicin—urinary bladder cancer	0.000351	0.000731	CcSEcCtD
Timolol—Immune system disorder—Methotrexate—urinary bladder cancer	0.00035	0.00073	CcSEcCtD
Timolol—Dizziness—Fluorouracil—urinary bladder cancer	0.00035	0.00073	CcSEcCtD
Timolol—Visual impairment—Epirubicin—urinary bladder cancer	0.000349	0.000729	CcSEcCtD
Timolol—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000349	0.000728	CcSEcCtD
Timolol—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000349	0.000727	CcSEcCtD
Timolol—Diarrhoea—Cisplatin—urinary bladder cancer	0.000343	0.000716	CcSEcCtD
Timolol—Alopecia—Methotrexate—urinary bladder cancer	0.000342	0.000714	CcSEcCtD
Timolol—Vomiting—Gemcitabine—urinary bladder cancer	0.000342	0.000713	CcSEcCtD
Timolol—Bradycardia—Doxorubicin—urinary bladder cancer	0.000342	0.000712	CcSEcCtD
Timolol—Mental disorder—Methotrexate—urinary bladder cancer	0.000339	0.000708	CcSEcCtD
Timolol—Rash—Gemcitabine—urinary bladder cancer	0.000339	0.000708	CcSEcCtD
Timolol—Dermatitis—Gemcitabine—urinary bladder cancer	0.000339	0.000707	CcSEcCtD
Timolol—Eye disorder—Epirubicin—urinary bladder cancer	0.000339	0.000707	CcSEcCtD
Timolol—Hypersensitivity—Etoposide—urinary bladder cancer	0.000339	0.000706	CcSEcCtD
Timolol—Tinnitus—Epirubicin—urinary bladder cancer	0.000338	0.000705	CcSEcCtD
Timolol—Erythema—Methotrexate—urinary bladder cancer	0.000337	0.000703	CcSEcCtD
Timolol—Malnutrition—Methotrexate—urinary bladder cancer	0.000337	0.000703	CcSEcCtD
Timolol—Headache—Gemcitabine—urinary bladder cancer	0.000337	0.000703	CcSEcCtD
Timolol—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000337	0.000702	CcSEcCtD
Timolol—Vomiting—Fluorouracil—urinary bladder cancer	0.000336	0.000702	CcSEcCtD
Timolol—Rhinitis—Doxorubicin—urinary bladder cancer	0.000336	0.000701	CcSEcCtD
Timolol—Rash—Fluorouracil—urinary bladder cancer	0.000334	0.000696	CcSEcCtD
Timolol—Dermatitis—Fluorouracil—urinary bladder cancer	0.000333	0.000695	CcSEcCtD
Timolol—Headache—Fluorouracil—urinary bladder cancer	0.000332	0.000691	CcSEcCtD
Timolol—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000331	0.000689	CcSEcCtD
Timolol—Dysgeusia—Methotrexate—urinary bladder cancer	0.00033	0.000689	CcSEcCtD
Timolol—Asthenia—Etoposide—urinary bladder cancer	0.00033	0.000687	CcSEcCtD
Timolol—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.00033	0.000687	CcSEcCtD
Timolol—Angiopathy—Epirubicin—urinary bladder cancer	0.000329	0.000686	CcSEcCtD
Timolol—Immune system disorder—Epirubicin—urinary bladder cancer	0.000328	0.000683	CcSEcCtD
Timolol—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000327	0.000681	CcSEcCtD
Timolol—Pruritus—Etoposide—urinary bladder cancer	0.000325	0.000678	CcSEcCtD
Timolol—Arrhythmia—Epirubicin—urinary bladder cancer	0.000324	0.000675	CcSEcCtD
Timolol—Visual impairment—Doxorubicin—urinary bladder cancer	0.000323	0.000674	CcSEcCtD
Timolol—Alopecia—Epirubicin—urinary bladder cancer	0.00032	0.000668	CcSEcCtD
Timolol—Nausea—Gemcitabine—urinary bladder cancer	0.00032	0.000667	CcSEcCtD
Timolol—Vomiting—Cisplatin—urinary bladder cancer	0.000319	0.000665	CcSEcCtD
Timolol—Vision blurred—Methotrexate—urinary bladder cancer	0.000318	0.000663	CcSEcCtD
Timolol—Mental disorder—Epirubicin—urinary bladder cancer	0.000318	0.000662	CcSEcCtD
Timolol—Rash—Cisplatin—urinary bladder cancer	0.000316	0.000659	CcSEcCtD
Timolol—Dermatitis—Cisplatin—urinary bladder cancer	0.000316	0.000659	CcSEcCtD
Timolol—Malnutrition—Epirubicin—urinary bladder cancer	0.000316	0.000658	CcSEcCtD
Timolol—Erythema—Epirubicin—urinary bladder cancer	0.000316	0.000658	CcSEcCtD
Timolol—Diarrhoea—Etoposide—urinary bladder cancer	0.000314	0.000656	CcSEcCtD
Timolol—Nausea—Fluorouracil—urinary bladder cancer	0.000314	0.000655	CcSEcCtD
Timolol—Eye disorder—Doxorubicin—urinary bladder cancer	0.000314	0.000654	CcSEcCtD
Timolol—Tinnitus—Doxorubicin—urinary bladder cancer	0.000313	0.000652	CcSEcCtD
Timolol—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000311	0.000649	CcSEcCtD
Timolol—Tension—Epirubicin—urinary bladder cancer	0.00031	0.000646	CcSEcCtD
Timolol—Dysgeusia—Epirubicin—urinary bladder cancer	0.000309	0.000644	CcSEcCtD
Timolol—Nervousness—Epirubicin—urinary bladder cancer	0.000307	0.000639	CcSEcCtD
Timolol—Angiopathy—Doxorubicin—urinary bladder cancer	0.000304	0.000635	CcSEcCtD
Timolol—Dizziness—Etoposide—urinary bladder cancer	0.000304	0.000634	CcSEcCtD
Timolol—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000303	0.000632	CcSEcCtD
Timolol—Vertigo—Methotrexate—urinary bladder cancer	0.000303	0.000632	CcSEcCtD
Timolol—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000302	0.00063	CcSEcCtD
Timolol—Arrhythmia—Doxorubicin—urinary bladder cancer	0.0003	0.000625	CcSEcCtD
Timolol—Nausea—Cisplatin—urinary bladder cancer	0.000298	0.000621	CcSEcCtD
Timolol—Vision blurred—Epirubicin—urinary bladder cancer	0.000297	0.00062	CcSEcCtD
Timolol—Alopecia—Doxorubicin—urinary bladder cancer	0.000296	0.000618	CcSEcCtD
Timolol—Cough—Methotrexate—urinary bladder cancer	0.000294	0.000614	CcSEcCtD
Timolol—Mental disorder—Doxorubicin—urinary bladder cancer	0.000294	0.000613	CcSEcCtD
Timolol—Vomiting—Etoposide—urinary bladder cancer	0.000292	0.000609	CcSEcCtD
Timolol—Erythema—Doxorubicin—urinary bladder cancer	0.000292	0.000609	CcSEcCtD
Timolol—Malnutrition—Doxorubicin—urinary bladder cancer	0.000292	0.000609	CcSEcCtD
Timolol—Rash—Etoposide—urinary bladder cancer	0.00029	0.000604	CcSEcCtD
Timolol—Dermatitis—Etoposide—urinary bladder cancer	0.000289	0.000604	CcSEcCtD
Timolol—Headache—Etoposide—urinary bladder cancer	0.000288	0.0006	CcSEcCtD
Timolol—Chest pain—Methotrexate—urinary bladder cancer	0.000287	0.000599	CcSEcCtD
Timolol—Myalgia—Methotrexate—urinary bladder cancer	0.000287	0.000599	CcSEcCtD
Timolol—Arthralgia—Methotrexate—urinary bladder cancer	0.000287	0.000599	CcSEcCtD
Timolol—Tension—Doxorubicin—urinary bladder cancer	0.000287	0.000598	CcSEcCtD
Timolol—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000286	0.000596	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000285	0.000595	CcSEcCtD
Timolol—Discomfort—Methotrexate—urinary bladder cancer	0.000284	0.000592	CcSEcCtD
Timolol—Nervousness—Doxorubicin—urinary bladder cancer	0.000284	0.000591	CcSEcCtD
Timolol—Vertigo—Epirubicin—urinary bladder cancer	0.000284	0.000591	CcSEcCtD
Timolol—Syncope—Epirubicin—urinary bladder cancer	0.000283	0.00059	CcSEcCtD
Timolol—Palpitations—Epirubicin—urinary bladder cancer	0.000279	0.000582	CcSEcCtD
Timolol—Confusional state—Methotrexate—urinary bladder cancer	0.000278	0.000579	CcSEcCtD
Timolol—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000277	0.000578	CcSEcCtD
Timolol—Cough—Epirubicin—urinary bladder cancer	0.000275	0.000574	CcSEcCtD
Timolol—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000275	0.000574	CcSEcCtD
Timolol—Vision blurred—Doxorubicin—urinary bladder cancer	0.000275	0.000574	CcSEcCtD
Timolol—Infection—Methotrexate—urinary bladder cancer	0.000273	0.00057	CcSEcCtD
Timolol—Nausea—Etoposide—urinary bladder cancer	0.000273	0.000569	CcSEcCtD
Timolol—Hypertension—Epirubicin—urinary bladder cancer	0.000273	0.000568	CcSEcCtD
Timolol—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00027	0.000563	CcSEcCtD
Timolol—ABCB1—lymph node—urinary bladder cancer	0.000269	0.00923	CbGeAlD
Timolol—Myalgia—Epirubicin—urinary bladder cancer	0.000269	0.00056	CcSEcCtD
Timolol—Chest pain—Epirubicin—urinary bladder cancer	0.000269	0.00056	CcSEcCtD
Timolol—Arthralgia—Epirubicin—urinary bladder cancer	0.000269	0.00056	CcSEcCtD
Timolol—Anxiety—Epirubicin—urinary bladder cancer	0.000268	0.000558	CcSEcCtD
Timolol—Skin disorder—Methotrexate—urinary bladder cancer	0.000267	0.000557	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000267	0.000556	CcSEcCtD
Timolol—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000266	0.000555	CcSEcCtD
Timolol—Discomfort—Epirubicin—urinary bladder cancer	0.000266	0.000554	CcSEcCtD
Timolol—Dry mouth—Epirubicin—urinary bladder cancer	0.000263	0.000548	CcSEcCtD
Timolol—Vertigo—Doxorubicin—urinary bladder cancer	0.000262	0.000547	CcSEcCtD
Timolol—Anorexia—Methotrexate—urinary bladder cancer	0.000262	0.000547	CcSEcCtD
Timolol—Syncope—Doxorubicin—urinary bladder cancer	0.000262	0.000546	CcSEcCtD
Timolol—Confusional state—Epirubicin—urinary bladder cancer	0.00026	0.000542	CcSEcCtD
Timolol—Palpitations—Doxorubicin—urinary bladder cancer	0.000258	0.000538	CcSEcCtD
Timolol—Oedema—Epirubicin—urinary bladder cancer	0.000258	0.000537	CcSEcCtD
Timolol—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000258	0.000537	CcSEcCtD
Timolol—Hypotension—Methotrexate—urinary bladder cancer	0.000257	0.000536	CcSEcCtD
Timolol—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000257	0.000535	CcSEcCtD
Timolol—Infection—Epirubicin—urinary bladder cancer	0.000256	0.000534	CcSEcCtD
Timolol—Cough—Doxorubicin—urinary bladder cancer	0.000255	0.000531	CcSEcCtD
Timolol—Shock—Epirubicin—urinary bladder cancer	0.000253	0.000528	CcSEcCtD
Timolol—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000253	0.000527	CcSEcCtD
Timolol—Hypertension—Doxorubicin—urinary bladder cancer	0.000252	0.000526	CcSEcCtD
Timolol—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000251	0.000523	CcSEcCtD
Timolol—Skin disorder—Epirubicin—urinary bladder cancer	0.00025	0.000522	CcSEcCtD
Timolol—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000249	0.000519	CcSEcCtD
Timolol—Insomnia—Methotrexate—urinary bladder cancer	0.000249	0.000519	CcSEcCtD
Timolol—Chest pain—Doxorubicin—urinary bladder cancer	0.000249	0.000518	CcSEcCtD
Timolol—Arthralgia—Doxorubicin—urinary bladder cancer	0.000249	0.000518	CcSEcCtD
Timolol—Myalgia—Doxorubicin—urinary bladder cancer	0.000249	0.000518	CcSEcCtD
Timolol—Anxiety—Doxorubicin—urinary bladder cancer	0.000248	0.000517	CcSEcCtD
Timolol—Paraesthesia—Methotrexate—urinary bladder cancer	0.000247	0.000515	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000247	0.000515	CcSEcCtD
Timolol—Discomfort—Doxorubicin—urinary bladder cancer	0.000246	0.000512	CcSEcCtD
Timolol—Anorexia—Epirubicin—urinary bladder cancer	0.000246	0.000512	CcSEcCtD
Timolol—Dyspnoea—Methotrexate—urinary bladder cancer	0.000245	0.000512	CcSEcCtD
Timolol—Somnolence—Methotrexate—urinary bladder cancer	0.000245	0.00051	CcSEcCtD
Timolol—Dry mouth—Doxorubicin—urinary bladder cancer	0.000243	0.000507	CcSEcCtD
Timolol—Dyspepsia—Methotrexate—urinary bladder cancer	0.000242	0.000505	CcSEcCtD
Timolol—Hypotension—Epirubicin—urinary bladder cancer	0.000241	0.000502	CcSEcCtD
Timolol—Confusional state—Doxorubicin—urinary bladder cancer	0.00024	0.000501	CcSEcCtD
Timolol—Decreased appetite—Methotrexate—urinary bladder cancer	0.000239	0.000499	CcSEcCtD
Timolol—Oedema—Doxorubicin—urinary bladder cancer	0.000238	0.000497	CcSEcCtD
Timolol—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000238	0.000497	CcSEcCtD
Timolol—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000238	0.000496	CcSEcCtD
Timolol—Fatigue—Methotrexate—urinary bladder cancer	0.000237	0.000495	CcSEcCtD
Timolol—Infection—Doxorubicin—urinary bladder cancer	0.000237	0.000494	CcSEcCtD
Timolol—Pain—Methotrexate—urinary bladder cancer	0.000235	0.000491	CcSEcCtD
Timolol—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000235	0.000489	CcSEcCtD
Timolol—Shock—Doxorubicin—urinary bladder cancer	0.000235	0.000489	CcSEcCtD
Timolol—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000234	0.000487	CcSEcCtD
Timolol—Insomnia—Epirubicin—urinary bladder cancer	0.000233	0.000486	CcSEcCtD
Timolol—Skin disorder—Doxorubicin—urinary bladder cancer	0.000232	0.000483	CcSEcCtD
Timolol—Paraesthesia—Epirubicin—urinary bladder cancer	0.000231	0.000482	CcSEcCtD
Timolol—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.00023	0.00048	CcSEcCtD
Timolol—Dyspnoea—Epirubicin—urinary bladder cancer	0.00023	0.000479	CcSEcCtD
Timolol—Somnolence—Epirubicin—urinary bladder cancer	0.000229	0.000478	CcSEcCtD
Timolol—Anorexia—Doxorubicin—urinary bladder cancer	0.000227	0.000474	CcSEcCtD
Timolol—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000227	0.000473	CcSEcCtD
Timolol—Dyspepsia—Epirubicin—urinary bladder cancer	0.000227	0.000473	CcSEcCtD
Timolol—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000225	0.000469	CcSEcCtD
Timolol—Decreased appetite—Epirubicin—urinary bladder cancer	0.000224	0.000467	CcSEcCtD
Timolol—Hypotension—Doxorubicin—urinary bladder cancer	0.000223	0.000464	CcSEcCtD
Timolol—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000222	0.000464	CcSEcCtD
Timolol—Fatigue—Epirubicin—urinary bladder cancer	0.000222	0.000463	CcSEcCtD
Timolol—Pain—Epirubicin—urinary bladder cancer	0.00022	0.000459	CcSEcCtD
Timolol—Urticaria—Methotrexate—urinary bladder cancer	0.000219	0.000456	CcSEcCtD
Timolol—Abdominal pain—Methotrexate—urinary bladder cancer	0.000218	0.000454	CcSEcCtD
Timolol—Body temperature increased—Methotrexate—urinary bladder cancer	0.000218	0.000454	CcSEcCtD
Timolol—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000217	0.000453	CcSEcCtD
Timolol—Insomnia—Doxorubicin—urinary bladder cancer	0.000216	0.00045	CcSEcCtD
Timolol—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000214	0.000446	CcSEcCtD
Timolol—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000213	0.000443	CcSEcCtD
Timolol—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000212	0.000443	CcSEcCtD
Timolol—Somnolence—Doxorubicin—urinary bladder cancer	0.000212	0.000442	CcSEcCtD
Timolol—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000211	0.000439	CcSEcCtD
Timolol—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00021	0.000437	CcSEcCtD
Timolol—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000207	0.000432	CcSEcCtD
Timolol—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000206	0.000429	CcSEcCtD
Timolol—Fatigue—Doxorubicin—urinary bladder cancer	0.000206	0.000428	CcSEcCtD
Timolol—Urticaria—Epirubicin—urinary bladder cancer	0.000205	0.000427	CcSEcCtD
Timolol—Pain—Doxorubicin—urinary bladder cancer	0.000204	0.000425	CcSEcCtD
Timolol—Abdominal pain—Epirubicin—urinary bladder cancer	0.000204	0.000425	CcSEcCtD
Timolol—Body temperature increased—Epirubicin—urinary bladder cancer	0.000204	0.000425	CcSEcCtD
Timolol—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000203	0.000423	CcSEcCtD
Timolol—Asthenia—Methotrexate—urinary bladder cancer	0.000198	0.000412	CcSEcCtD
Timolol—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000196	0.00041	CcSEcCtD
Timolol—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000195	0.000406	CcSEcCtD
Timolol—Pruritus—Methotrexate—urinary bladder cancer	0.000195	0.000406	CcSEcCtD
Timolol—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00019	0.000396	CcSEcCtD
Timolol—Urticaria—Doxorubicin—urinary bladder cancer	0.000189	0.000395	CcSEcCtD
Timolol—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000188	0.000393	CcSEcCtD
Timolol—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000188	0.000393	CcSEcCtD
Timolol—Diarrhoea—Methotrexate—urinary bladder cancer	0.000188	0.000393	CcSEcCtD
Timolol—Asthenia—Epirubicin—urinary bladder cancer	0.000185	0.000385	CcSEcCtD
Timolol—Pruritus—Epirubicin—urinary bladder cancer	0.000182	0.00038	CcSEcCtD
Timolol—Dizziness—Methotrexate—urinary bladder cancer	0.000182	0.00038	CcSEcCtD
Timolol—Diarrhoea—Epirubicin—urinary bladder cancer	0.000176	0.000368	CcSEcCtD
Timolol—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000176	0.000366	CcSEcCtD
Timolol—Vomiting—Methotrexate—urinary bladder cancer	0.000175	0.000365	CcSEcCtD
Timolol—Rash—Methotrexate—urinary bladder cancer	0.000174	0.000362	CcSEcCtD
Timolol—Dermatitis—Methotrexate—urinary bladder cancer	0.000173	0.000362	CcSEcCtD
Timolol—Headache—Methotrexate—urinary bladder cancer	0.000172	0.00036	CcSEcCtD
Timolol—Asthenia—Doxorubicin—urinary bladder cancer	0.000171	0.000357	CcSEcCtD
Timolol—Dizziness—Epirubicin—urinary bladder cancer	0.00017	0.000355	CcSEcCtD
Timolol—Pruritus—Doxorubicin—urinary bladder cancer	0.000169	0.000352	CcSEcCtD
Timolol—Vomiting—Epirubicin—urinary bladder cancer	0.000164	0.000342	CcSEcCtD
Timolol—Nausea—Methotrexate—urinary bladder cancer	0.000164	0.000341	CcSEcCtD
Timolol—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000163	0.00034	CcSEcCtD
Timolol—Rash—Epirubicin—urinary bladder cancer	0.000162	0.000339	CcSEcCtD
Timolol—Dermatitis—Epirubicin—urinary bladder cancer	0.000162	0.000338	CcSEcCtD
Timolol—Headache—Epirubicin—urinary bladder cancer	0.000161	0.000336	CcSEcCtD
Timolol—Dizziness—Doxorubicin—urinary bladder cancer	0.000158	0.000329	CcSEcCtD
Timolol—Nausea—Epirubicin—urinary bladder cancer	0.000153	0.000319	CcSEcCtD
Timolol—Vomiting—Doxorubicin—urinary bladder cancer	0.000152	0.000316	CcSEcCtD
Timolol—Rash—Doxorubicin—urinary bladder cancer	0.00015	0.000313	CcSEcCtD
Timolol—Dermatitis—Doxorubicin—urinary bladder cancer	0.00015	0.000313	CcSEcCtD
Timolol—Headache—Doxorubicin—urinary bladder cancer	0.000149	0.000311	CcSEcCtD
Timolol—Nausea—Doxorubicin—urinary bladder cancer	0.000142	0.000295	CcSEcCtD
Timolol—CYP2D6—Metapathway biotransformation—NAT2—urinary bladder cancer	2.77e-05	0.00413	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—FAS—urinary bladder cancer	2.46e-05	0.00366	CbGpPWpGaD
Timolol—CYP2C19—Biological oxidations—HPGDS—urinary bladder cancer	2.44e-05	0.00364	CbGpPWpGaD
Timolol—CYP2C19—Biological oxidations—GSTT1—urinary bladder cancer	2.37e-05	0.00353	CbGpPWpGaD
Timolol—CYP2C19—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	2.28e-05	0.0034	CbGpPWpGaD
Timolol—CYP2D6—Biological oxidations—HPGDS—urinary bladder cancer	2.24e-05	0.00335	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	2.19e-05	0.00326	CbGpPWpGaD
Timolol—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	2.18e-05	0.00325	CbGpPWpGaD
Timolol—CYP2D6—Biological oxidations—GSTT1—urinary bladder cancer	2.18e-05	0.00324	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	2.18e-05	0.00324	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	1.99e-05	0.00296	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—HDAC4—urinary bladder cancer	1.82e-05	0.00272	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	1.76e-05	0.00263	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	1.75e-05	0.00261	CbGpPWpGaD
Timolol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	1.64e-05	0.00245	CbGpPWpGaD
Timolol—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	1.64e-05	0.00245	CbGpPWpGaD
Timolol—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	1.62e-05	0.00241	CbGpPWpGaD
Timolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	1.61e-05	0.00241	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—GLI1—urinary bladder cancer	1.53e-05	0.00228	CbGpPWpGaD
Timolol—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	1.51e-05	0.00225	CbGpPWpGaD
Timolol—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	1.51e-05	0.00225	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	1.5e-05	0.00223	CbGpPWpGaD
Timolol—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	1.49e-05	0.00222	CbGpPWpGaD
Timolol—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	1.49e-05	0.00222	CbGpPWpGaD
Timolol—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	1.48e-05	0.00221	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	1.44e-05	0.00214	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	1.43e-05	0.00214	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	1.39e-05	0.00208	CbGpPWpGaD
Timolol—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	1.39e-05	0.00207	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	1.37e-05	0.00204	CbGpPWpGaD
Timolol—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	1.37e-05	0.00204	CbGpPWpGaD
Timolol—ADRB3—GPCR ligand binding—CXCL8—urinary bladder cancer	1.23e-05	0.00183	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	1.21e-05	0.00181	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	1.17e-05	0.00174	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HDAC4—urinary bladder cancer	1.08e-05	0.00161	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	1.07e-05	0.0016	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	1.07e-05	0.00159	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	1.06e-05	0.00158	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HDAC4—urinary bladder cancer	1.06e-05	0.00158	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—RBX1—urinary bladder cancer	1.05e-05	0.00156	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	1.04e-05	0.00156	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	1e-05	0.0015	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TSC1—urinary bladder cancer	9.84e-06	0.00147	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	9.81e-06	0.00146	CbGpPWpGaD
Timolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	9.58e-06	0.00143	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	9.53e-06	0.00142	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—NAT1—urinary bladder cancer	9.53e-06	0.00142	CbGpPWpGaD
Timolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	9.38e-06	0.0014	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	9.37e-06	0.0014	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—JAG1—urinary bladder cancer	9.36e-06	0.0014	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	9.31e-06	0.00139	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTO2—urinary bladder cancer	9.3e-06	0.00139	CbGpPWpGaD
Timolol—ABCB1—Metabolism—NAT1—urinary bladder cancer	9.3e-06	0.00139	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	9.24e-06	0.00138	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	9.2e-06	0.00137	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—GLI1—urinary bladder cancer	9.06e-06	0.00135	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—GLI1—urinary bladder cancer	8.86e-06	0.00132	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	8.76e-06	0.00131	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NAT1—urinary bladder cancer	8.76e-06	0.00131	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	8.71e-06	0.0013	CbGpPWpGaD
Timolol—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	8.5e-06	0.00127	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	8.01e-06	0.00119	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—RHOA—urinary bladder cancer	7.92e-06	0.00118	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	7.9e-06	0.00118	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	7.84e-06	0.00117	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	7.8e-06	0.00116	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	7.66e-06	0.00114	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	7.63e-06	0.00114	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—S100B—urinary bladder cancer	7.58e-06	0.00113	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	7.41e-06	0.0011	CbGpPWpGaD
Timolol—ADRB1—GPCR ligand binding—CXCL8—urinary bladder cancer	7.3e-06	0.00109	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	7.23e-06	0.00108	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	7.22e-06	0.00108	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	7.21e-06	0.00108	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—RHOA—urinary bladder cancer	7.19e-06	0.00107	CbGpPWpGaD
Timolol—ADRB2—GPCR ligand binding—CXCL8—urinary bladder cancer	7.14e-06	0.00106	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PRSS3—urinary bladder cancer	7.05e-06	0.00105	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—CXCL8—urinary bladder cancer	6.95e-06	0.00104	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	6.89e-06	0.00103	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—NCOR1—urinary bladder cancer	6.82e-06	0.00102	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	6.81e-06	0.00102	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	6.67e-06	0.000994	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	6.65e-06	0.000992	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—IL2—urinary bladder cancer	6.64e-06	0.00099	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	6.64e-06	0.00099	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	6.34e-06	0.000946	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—CXCL8—urinary bladder cancer	6.31e-06	0.000941	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—RBX1—urinary bladder cancer	6.21e-06	0.000926	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	6.17e-06	0.00092	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—RBX1—urinary bladder cancer	6.07e-06	0.000906	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—IL2—urinary bladder cancer	6.03e-06	0.000899	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TERT—urinary bladder cancer	6.01e-06	0.000896	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TSC1—urinary bladder cancer	5.84e-06	0.00087	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.79e-06	0.000863	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—TYMP—urinary bladder cancer	5.77e-06	0.00086	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TSC1—urinary bladder cancer	5.71e-06	0.000851	CbGpPWpGaD
Timolol—ABCB1—Metabolism—TYMP—urinary bladder cancer	5.63e-06	0.00084	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—JAG1—urinary bladder cancer	5.56e-06	0.000829	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.54e-06	0.000826	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	5.53e-06	0.000824	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—FGFR3—urinary bladder cancer	5.51e-06	0.000822	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—JAG1—urinary bladder cancer	5.44e-06	0.00081	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	5.41e-06	0.000806	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—ESR1—urinary bladder cancer	5.36e-06	0.000798	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—TYMP—urinary bladder cancer	5.31e-06	0.000791	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—NAT2—urinary bladder cancer	5.22e-06	0.000778	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	5.15e-06	0.000768	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	5.11e-06	0.000761	CbGpPWpGaD
Timolol—ABCB1—Metabolism—NAT2—urinary bladder cancer	5.09e-06	0.000759	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NAT2—urinary bladder cancer	4.8e-06	0.000716	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—RHOA—urinary bladder cancer	4.7e-06	0.0007	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CREBBP—urinary bladder cancer	4.69e-06	0.0007	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IGF1—urinary bladder cancer	4.64e-06	0.000691	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—EGFR—urinary bladder cancer	4.61e-06	0.000688	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—RHOA—urinary bladder cancer	4.6e-06	0.000685	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	4.54e-06	0.000677	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—RRM2—urinary bladder cancer	4.51e-06	0.000672	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—S100B—urinary bladder cancer	4.5e-06	0.000671	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—S100B—urinary bladder cancer	4.4e-06	0.000656	CbGpPWpGaD
Timolol—ABCB1—Metabolism—RRM2—urinary bladder cancer	4.4e-06	0.000656	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—KRAS—urinary bladder cancer	4.36e-06	0.00065	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—RHOA—urinary bladder cancer	4.27e-06	0.000636	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—RHOA—urinary bladder cancer	4.25e-06	0.000633	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—RHOA—urinary bladder cancer	4.17e-06	0.000622	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	4.17e-06	0.000622	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ENO2—urinary bladder cancer	4.17e-06	0.000622	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.15e-06	0.000618	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—RRM2—urinary bladder cancer	4.14e-06	0.000618	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—CXCL8—urinary bladder cancer	4.12e-06	0.000615	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ENO2—urinary bladder cancer	4.07e-06	0.000607	CbGpPWpGaD
Timolol—ABCB1—Metabolism—HPGDS—urinary bladder cancer	4.07e-06	0.000607	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	4.05e-06	0.000603	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NCOR1—urinary bladder cancer	4.05e-06	0.000603	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—CXCL8—urinary bladder cancer	4.03e-06	0.000601	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.98e-06	0.000594	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NCOR1—urinary bladder cancer	3.96e-06	0.00059	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTT1—urinary bladder cancer	3.95e-06	0.000589	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—IL2—urinary bladder cancer	3.94e-06	0.000588	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—ERBB2—urinary bladder cancer	3.93e-06	0.000586	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—IL2—urinary bladder cancer	3.86e-06	0.000575	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ENO2—urinary bladder cancer	3.84e-06	0.000572	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	3.84e-06	0.000572	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—CXCL8—urinary bladder cancer	3.75e-06	0.000558	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CXCL8—urinary bladder cancer	3.73e-06	0.000556	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	3.72e-06	0.000555	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—HRAS—urinary bladder cancer	3.7e-06	0.000552	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.7e-06	0.000551	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—CXCL8—urinary bladder cancer	3.66e-06	0.000546	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—IL2—urinary bladder cancer	3.58e-06	0.000534	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TERT—urinary bladder cancer	3.57e-06	0.000532	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IL2—urinary bladder cancer	3.56e-06	0.000531	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—IL2—urinary bladder cancer	3.5e-06	0.000522	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TERT—urinary bladder cancer	3.49e-06	0.00052	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CCND1—urinary bladder cancer	3.47e-06	0.000518	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MMP9—urinary bladder cancer	3.37e-06	0.000503	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—NQO1—urinary bladder cancer	3.36e-06	0.000501	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CDKN1A—urinary bladder cancer	3.36e-06	0.000501	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PTEN—urinary bladder cancer	3.35e-06	0.0005	CbGpPWpGaD
Timolol—ABCB1—Metabolism—NQO1—urinary bladder cancer	3.28e-06	0.000489	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FGFR3—urinary bladder cancer	3.27e-06	0.000488	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.26e-06	0.000486	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FGFR3—urinary bladder cancer	3.2e-06	0.000477	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—EP300—urinary bladder cancer	3.2e-06	0.000477	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ESR1—urinary bladder cancer	3.18e-06	0.000474	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ESR1—urinary bladder cancer	3.11e-06	0.000464	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—SRC—urinary bladder cancer	3.11e-06	0.000463	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NQO1—urinary bladder cancer	3.09e-06	0.000461	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.85e-06	0.000424	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	2.81e-06	0.000418	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CREBBP—urinary bladder cancer	2.79e-06	0.000415	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MYC—urinary bladder cancer	2.79e-06	0.000415	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IGF1—urinary bladder cancer	2.75e-06	0.00041	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTP1—urinary bladder cancer	2.74e-06	0.000408	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—EGFR—urinary bladder cancer	2.74e-06	0.000408	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CREBBP—urinary bladder cancer	2.73e-06	0.000406	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—EGFR—urinary bladder cancer	2.72e-06	0.000406	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.71e-06	0.000405	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IGF1—urinary bladder cancer	2.69e-06	0.000401	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—EGFR—urinary bladder cancer	2.68e-06	0.000399	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—TYMS—urinary bladder cancer	2.61e-06	0.000389	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—KRAS—urinary bladder cancer	2.59e-06	0.000386	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	2.58e-06	0.000385	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	2.58e-06	0.000384	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	2.58e-06	0.000384	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—KRAS—urinary bladder cancer	2.57e-06	0.000384	CbGpPWpGaD
Timolol—ABCB1—Metabolism—TYMS—urinary bladder cancer	2.55e-06	0.000379	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—KRAS—urinary bladder cancer	2.53e-06	0.000377	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—RHOA—urinary bladder cancer	2.52e-06	0.000376	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTM1—urinary bladder cancer	2.52e-06	0.000375	CbGpPWpGaD
Timolol—ABCB1—Metabolism—NCOR1—urinary bladder cancer	2.52e-06	0.000375	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GPX1—urinary bladder cancer	2.47e-06	0.000368	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—RHOA—urinary bladder cancer	2.47e-06	0.000368	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	2.42e-06	0.000361	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GPX1—urinary bladder cancer	2.41e-06	0.000359	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—TYMS—urinary bladder cancer	2.4e-06	0.000358	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	2.37e-06	0.000353	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	2.37e-06	0.000353	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ERCC2—urinary bladder cancer	2.37e-06	0.000353	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ERBB2—urinary bladder cancer	2.33e-06	0.000348	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TP53—urinary bladder cancer	2.29e-06	0.000341	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ERBB2—urinary bladder cancer	2.28e-06	0.00034	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	2.28e-06	0.00034	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GPX1—urinary bladder cancer	2.27e-06	0.000338	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	2.23e-06	0.000332	CbGpPWpGaD
Timolol—ABCB1—Metabolism—MTHFR—urinary bladder cancer	2.22e-06	0.000331	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CXCL8—urinary bladder cancer	2.21e-06	0.00033	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—HRAS—urinary bladder cancer	2.2e-06	0.000328	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—HRAS—urinary bladder cancer	2.19e-06	0.000326	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CXCL8—urinary bladder cancer	2.16e-06	0.000323	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—HRAS—urinary bladder cancer	2.15e-06	0.000321	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IL2—urinary bladder cancer	2.11e-06	0.000315	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	2.1e-06	0.000312	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IL2—urinary bladder cancer	2.07e-06	0.000308	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CCND1—urinary bladder cancer	2.06e-06	0.000307	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CCND1—urinary bladder cancer	2.02e-06	0.000301	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MMP9—urinary bladder cancer	2e-06	0.000298	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.99e-06	0.000297	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PTEN—urinary bladder cancer	1.99e-06	0.000297	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MMP9—urinary bladder cancer	1.96e-06	0.000292	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CDKN1A—urinary bladder cancer	1.95e-06	0.000291	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PTEN—urinary bladder cancer	1.95e-06	0.00029	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EP300—urinary bladder cancer	1.9e-06	0.000283	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EP300—urinary bladder cancer	1.86e-06	0.000277	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.85e-06	0.000275	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SRC—urinary bladder cancer	1.85e-06	0.000275	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SRC—urinary bladder cancer	1.8e-06	0.000269	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.8e-06	0.000269	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.77e-06	0.000265	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.73e-06	0.000258	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.7e-06	0.000253	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MYC—urinary bladder cancer	1.65e-06	0.000246	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.63e-06	0.000243	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MYC—urinary bladder cancer	1.62e-06	0.000241	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EGFR—urinary bladder cancer	1.62e-06	0.000241	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EGFR—urinary bladder cancer	1.58e-06	0.000236	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KRAS—urinary bladder cancer	1.53e-06	0.000228	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KRAS—urinary bladder cancer	1.49e-06	0.000223	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	1.45e-06	0.000217	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.42e-06	0.000211	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TP53—urinary bladder cancer	1.36e-06	0.000202	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.34e-06	0.000199	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TP53—urinary bladder cancer	1.33e-06	0.000198	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HRAS—urinary bladder cancer	1.3e-06	0.000194	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HRAS—urinary bladder cancer	1.27e-06	0.000189	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PTEN—urinary bladder cancer	1.27e-06	0.000189	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PTEN—urinary bladder cancer	1.24e-06	0.000184	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—EP300—urinary bladder cancer	1.21e-06	0.00018	CbGpPWpGaD
Timolol—ABCB1—Metabolism—EP300—urinary bladder cancer	1.18e-06	0.000176	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.17e-06	0.000174	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.11e-06	0.000166	CbGpPWpGaD
